1.0
22. Dez. 2016
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
BioTime successfully transitioned from blood products to stem cell focus at an excellent time, and attracted some strong backers with excellent resources and know-how.
Kontras
Internal management is scattered and unfocused. CEO Mike West consistently opts for expenditures based on personal whims and self-glorification rather than overall company well-being. Rewards are rarely based on merit.